T-DM1-related telangiectasias: a potential role in secondary bleeding events

Ann Oncol. 2015 Feb;26(2):436-7. doi: 10.1093/annonc/mdu533. Epub 2014 Nov 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Ado-Trastuzumab Emtansine
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Breast Neoplasms / drug therapy*
  • Clinical Trials, Phase III as Topic
  • Female
  • Hemorrhage / chemically induced*
  • Humans
  • Maytansine / adverse effects
  • Maytansine / analogs & derivatives*
  • Telangiectasis / chemically induced*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Maytansine
  • Trastuzumab
  • Ado-Trastuzumab Emtansine